PTPRC and renal cell carcinoma: Moreover, we showed that the number of DAPI+/CK+/CD45- CTCs was associated with the clinical stages of RCC, with 1.2-fold more CTCs present in late-stage (III and IV) patient blood compared to those with early-stage (I and II) disease (Figure 5B and Table 4).